Become a part of the Department that touches the lives of every American! At the Department of Health and Human Services (HHS) you can give back to your community, state, and country by making a difference in the lives of Americans everywhere. It is the principal agency for protecting the health of citizens. Join HHS and help to make our world healthier, safer, and better for all Americans.
This JOB ANNOUNCEMENT HAS BEEN EXTENDED AND WILL NOW CLOSE ON 4/17/2014.
This announcement is open continuous for 120 days with the following cut-off dates for certification:
- January 15, 2014
- February 14, 2014
- March 17, 2014
- April 17, 2014
As a Chemical Engineer in the Center for Drug Evaluation and Research, you will provide special scientific expertise in the areas of both chemistry and engineering to respond to issues related to pharmaceutical manufacturing, formulation development, and drug product performance.
This vacancy is also being announced concurrently with vacancy announcement HHS-FDA-CDER-MP-14-1005721 under merit promotion procedures. Please review that announcement to see if you are eligible for consideration under merit promotion procedures. NOTE: Applicants must apply separately for each announcement in order to be considered.
This job opportunity announcement may be used FDA-wide to fill additional vacancies within the same geographical location.
- Provides special scientific expertise in the areas of both chemistry and engineering to respond to issues related to pharmaceutical manufacturing, formulation development, and drug product performance.
- Provides technical leadership and guidance in the understanding and regulation of the physical/mechanical processes of manufacturing products and the related quality control procedures.
- Reviews a wide range of drug applications received from the pharmaceutical industry to determine the adequacy of Chemistry, Manufacturing, and Controls (CMC), conducts/manages research to develop new CMC standards, and improves existing standards.
- Prepares responses to the citizen petitions and other correspondence inquiries from congressional representatives, national and international organizations on matters related to the processes involved in the design, manufacture, and controls of generic drugs.